The human myeloperoxidase gene is regulated by LXR and PPARα ligands

被引:27
作者
Reynolds, Wanda F. [1 ]
Kumar, Alan P. [1 ]
Piedrafita, F. Javier [1 ]
机构
[1] Sidney Kimmel Can Ctr, San Diego, CA 92121 USA
关键词
myeloperoxidase; MPO; atherosclerosis; nuclear receptors; LXR; PPAR alpha; PPAR gamma; transgenic; macrophage; cholesterol;
D O I
10.1016/j.bbrc.2006.08.119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myeloperoxidase (MPO) is an oxidant-generating enzyme expressed in macrophages and implicated in atherosclerosis and cholesterol homeostasis. LXR alpha and PPAR alpha regulate genes involved in cholesterol metabolism and the inflammatory response in macrophages. Here, we examine the effect of LXR and PPAR alpha ligands on MPO expression. LXR and PPAR alpha, as heterodimers with RXR, are shown to bind overlapping sites in an Alu receptor response element (AluRRE) in the MPO promoter. The LXR ligand T0901317 suppresses MPO mRNA expression in primary human macrophages, and in bone marrow cells and macrophages from huMPO transgenic mice. The PPAR alpha ligand GW9578 downregulates MPO expression in GMCSF-macrophages, while upregulating in MCSF-macrophages. In contrast, the mouse MPO gene, which lacks the prim ate-specific AluRRE, is not regulated by LXR or PPAR alpha ligands. These findings identify human MPO as a novel LXR and PPAR alpha target gene, consistent with the role of these receptors in regulation of proinflammatory genes in macrophages. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:846 / 854
页数:9
相关论文
共 47 条
[1]   A novel principle for partial agonism of liver X receptor ligands - Competitive recruitment of activators and repressors [J].
Albers, M ;
Blume, B ;
Schlueter, T ;
Wright, MB ;
Kober, I ;
Kremoser, C ;
Deuschle, U ;
Koegl, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (08) :4920-4930
[2]   Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease [J].
Asselbergs, FW ;
Reynolds, WF ;
Cohen-Tervaert, JW ;
Jessurun, GAJ .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (06) :429-430
[3]   Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases [J].
Baldus, S ;
Eiserich, JP ;
Brennan, ML ;
Jackson, RM ;
Alexander, CB ;
Freeman, BA .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (07) :1010-1019
[4]   The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport [J].
Bergt, C ;
Pennathur, S ;
Fu, XY ;
Byun, J ;
O'Brien, K ;
McDonald, TO ;
Singh, P ;
Anantharamaiah, GM ;
Chait, A ;
Brunzell, J ;
Geary, RL ;
Oram, JF ;
Heinecke, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (35) :13032-13037
[5]   Prognostic value of myeloperoxidase in patients with chest pain [J].
Brennan, M ;
Penn, MS ;
Van Lente, F ;
Nambi, V ;
Shishehbor, MH ;
Aviles, RJ ;
Goormastic, M ;
Pepoy, ML ;
McErlean, ES ;
Topol, EJ ;
Nissen, SE ;
Hazen, SL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (17) :1595-1604
[6]   Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis [J].
Brennan, ML ;
Gaur, A ;
Pahuja, A ;
Lusis, AJ ;
Reynolds, WF .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 112 (1-2) :97-105
[7]   Transgenic mice express human MPO-463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in-463G males [J].
Castellani, Lawrence W. ;
Chang, James J. ;
Wang, Xuping ;
Lusis, Aldons J. ;
Reynolds, Wanda F. .
JOURNAL OF LIPID RESEARCH, 2006, 47 (07) :1366-1377
[8]   A PPARγ-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis [J].
Chawla, A ;
Boisvert, WA ;
Lee, CH ;
Laffitte, BA ;
Barak, Y ;
Joseph, SB ;
Liao, D ;
Nagy, L ;
Edwards, PA ;
Curtiss, LK ;
Evans, RM ;
Tontonoz, P .
MOLECULAR CELL, 2001, 7 (01) :161-171
[9]   PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].
Chinetti, G ;
Lestavel, S ;
Bocher, V ;
Remaley, AT ;
Neve, B ;
Torra, IP ;
Teissier, E ;
Minnich, A ;
Jaye, M ;
Duverger, N ;
Brewer, HB ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
NATURE MEDICINE, 2001, 7 (01) :53-58
[10]   MYELOPEROXIDASE, A CATALYST FOR LIPOPROTEIN OXIDATION, IS EXPRESSED IN HUMAN ATHEROSCLEROTIC LESIONS [J].
DAUGHERTY, A ;
DUNN, JL ;
RATERI, DL ;
HEINECKE, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :437-444